Marketing-authorisation holder · Canada
Jubilant Draximage Inc. Dba Jubilant Radiopharma
18 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
18 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
18 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DRAX EXAMETAZIME0.5 mg / vial · Powder For Solution | Technetium (99m tc) exametazime labelled cells | Canada | Marketed | 2022 |
| DRAXIMAGE DTPA20 mg / vial · Powder For Solution | Technetium (99m tc) pentetic acid | Canada | Marketed | 2002 |
| DRAXIMAGE GLUCEPTATE25 mg / vial + 3 mg / vial · Powder For Solution | Calcium glucoheptonate, Stannous | Canada | Marketed | 2002 |
| DRAXIMAGE MAA2.5 mg / vial · Powder For Solution | Albumin | Canada | Marketed | 1972 |
| DRAXIMAGE MDP10 mg / vial · Powder For Solution | Technetium (99m tc) medronic acid | Canada | Marketed | 1975 |
| DRAXIMAGE MDP-2525 mg / vial · Powder For Solution | Technetium (99m tc) medronic acid | Canada | Marketed | 2005 |
| DRAXIMAGE SESTAMIBI1 mg / vial · Powder For Solution | Technetium (99m tc) sestamibi | Canada | Marketed | 2009 |
| RUBY-FILL3.7 gbq / gen · Solution | Rubidium rb | Canada | Marketed | 2011 |
| DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP DIAGNOSTIC3.7 MBq · Capsule | Canada | Marketed | 2009 | |
| DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC7400 MBq · Capsule | Canada | Marketed | 2009 | |
| DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC925 MBq / VIAL · Solution | Canada | Marketed | 2009 | |
| DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC7400 MBq / VIAL · Solution | Canada | Marketed | 2009 | |
| HICON9.25 gbq / 0.25 ml · Kit, Solution | Canada | Not marketed | 2009 | |
| HICON37 gbq / ml · Kit, Solution | Canada | Not marketed | 2009 | |
| HICON18.5 gbq / 0.5 ml · Kit, Solution | Canada | Not marketed | 2009 | |
| DRAXIMAGE XENON XE 133370 MBq / VIAL · Gas | Xenon xe | Canada | Cancelled | |
| DRAXIMAGE XENON XE 133740 MBq · Gas | Xenon xe | Canada | Cancelled | |
| GADOPENTETATE DIMEGLUMINE INJECTION, USP469 mg / ml · Solution | Gadopentetic acid | Canada | Cancelled |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 18 | 15 | 3 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.